CARD11 Activators

PMA is a potent activator of protein kinase C (PKC). PKC activation phosphorylates CARD11, leading to its activation and the promotion of NF-κB signaling, which is essential for lymphocyte activation.

Ionomycin is a calcium ionophore that raises intracellular calcium levels. Increased calcium can activate NFAT, which cooperates with NF-κB, where CARD11 acts as a scaffold, enhancing its functional activity in T-cell receptor signaling.

Bryostatin 1 is a PKC modulator that can activate PKC isoforms. This activation can phosphorylate and activate CARD11, enhancing its scaffolding function in T-cell activation.

Forskolin increases intracellular cAMP levels, which can lead to activation of PKA. PKA phosphorylation can modulate CARD11 activity, thereby influencing T-cell receptor-mediated NF-κB activation.

Prostratin is an activator of PKC, which can phosphorylate CARD11, enhancing its activity and promoting downstream NF-κB signaling in lymphocytes.

Ingenol 3-angelate is a PKC activator that can induce phosphorylation of CARD11, thereby potentiating its role in activating NF-κB signaling pathways in T cells.

Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels, which can enhance the activation of NFAT and potentially cooperate with NF-κB signaling where CARD11 is a key component.

A23187 is a calcium ionophore that increases intracellular calcium, similar to ionomycin, and this rise in calcium can enhance NFAT activity, which synergizes with CARD11 in T-cell activation.

Anisomycin is a JNK activator. JNK pathway can influence T-cell activation and NF-κB signaling where CARD11 functions as a scaffold, enhancing its role in the signaling cascade.

Calcitriol modulates immune responses and can enhance NF-κB activity in a synergistic manner with CARD11 signaling in T cells, potentially through its effects on gene transcription regulation.